Novo Nordisk’s semaglutide and Eli Lilly’s tirzepatide — are now available in the Indian market. Here’s how they work, how ...

There is a bottomless appetite for news about weight-loss drugs. We cannot hear enough about the celebrities, politicians and ...

Several companies across various sectors on the Wall Street have seen some Seeking Alpha analyst activity, including both ...

In a breakthrough for incretin medicines, China’s National Medical Products Administration (NMPA) has approved Innovent’s ...

Though much of the dust has settled around Novo Nordisk and Eli Lilly’s crusade against compounded GLP-1s, the recent ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...

Rezpeg's promising Phase 2b data makes Nektar Therapeutics a strong contender in the AD market. Click here to read an ...

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...

In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...

Empagliflozin has kidney protective effects and reduces heart failure outcomes across baseline kidney function among patients ...

Mounjaro is one of the bestselling weight loss drugs. See what your options are if you want to invest in Mounjaro stock.

Jefferies analysts called the proxy filing, which is a standard disclosure after a merger agreement, “much more intriguing ...